Venturelab
close

The Venture Leaders Medtech 2021 kick off their roadshow to connect with international investors

18.08.2021 07:00, Isabelle Mitchell

The Swiss National Medtech Team is getting ready for the first-ever business development roadshow for medtech startups: The 10 Venture Leaders Medtech 2021 met in Lausanne to prepare for their roadshow to meet international investors, strengthen their networks and present their innovations to a global audience. Venture Leaders Medtech 2021 is organized by Venturelab and supported by EPF Lausanne, ETH Zurich, Hansjörg Wyss, Kellerhals Carrard, Paul Scherrer Institut, Swissnex Boston, University Zurich, Canton of Vaud, and Canton of Zurich.

For the first time, medtech startups get their own Venture Leaders program that will help them enter the global stage. “We are excited that medtech now has its own Venture Leaders program. Medtech has become such an important field in Switzerland, and we wanted to do justice to this development and the innovative power of the Swiss medtech industry,” said Jordi Montserrat, managing partner at Venturelab. “The Venture Leaders Medtech startups 2021 provide an impressive portfolio of high-quality solutions that have the potential to shape the global markets in regenerative medicine.”



The kick-off event marked the first time the 10 Venture Leaders Medtech met and presented their startups—nine startups pitched in person, and one startup participated online. During the one-day workshop at the EPFL Innovation Park in Lausanne, the 10 Venture Leaders Medtech focused on getting to know each other and preparing for the roadshow in the fall. Nicolas Mosimann, a partner and attorney at Kellerhals Carrard, provided his expertise on onboarding strategic investors. “I am so much looking forward to another Venture Leaders roadshow. This is a unique opportunity for our Swiss startups to showcase their cutting-edge technologies to U.S. investors and potential partners and further expand their network within the life sciences world,” said Mosimann. 



For the ten medtech entrepreneurs, the Venture Leaders program aims to provide them with expertise o enter the global stage, access to investors and experts, and exchanges with fellow entrepreneurs: “We expect that the Venture Leaders roadshow will help us get direct feedback from people already present in the local medtech ecosystem, and we hope to gain a comprehensive understanding of the challenges pertaining to the US market. We are also looking forward to making new contacts and sharing experiences with other Swiss medtech startups going through the same challenges as flowbone,” summarized Valérie Malfroy Camine, the COO of flowbone, her expectations for the Venture Leaders Medtech experience. 



For more information and updates on the Venture Leaders Medtech, follow the Venture Leaders Medtech 2021 team with #VleadersMedtech on social media or subscribe to our newsletter
 
Venture Leaders Medtech 2021 is organized by Venturelab and supported by EPF Lausanne, ETH Zurich, Hansjörg Wyss, Kellerhals Carrard, Paul Scherrer Institut, Swissnex Boston, University Zurich, Canton of Vaud, and Canton of Zurich.


Learn more about the Venture Leaders Medtech 2021: 

CustomSurg AG: Rethinking Treatment of Complex Trauma Surgery

Complex bone fractures lead to decrease in quality of life and loss of productivity, with 1 in 4 failures. CustomSurg addresses the unmet clinical need to know fixation stability, by changing subject... Read more

Emovo Care SA: Therapy while living

Emovo Care (https://emovocare.com/ ) is a medical device company developing robotic systems to support people with motor impairments Exploiting our innovative patent-protected soft-robotics tech an... Read more

flowbone SA: Restoring hip strength to resist breaking

FLOWBONE is involved in the development and promotion of a revolutionary biomaterial for the minimal-invasive augmentation of fragile bones. FLOWBONE, follows a completely new treatment approach allow... Read more

Gondola Medical Technologies SA: Treatment for motor symptoms of neurodegenerative diseases

Gondola Medical Technologies is a Swiss MedTech company offering Gondola AMPS, a clinically-proven, side-effect free and non-invasive therapy to improve walking, empowering patients to move better and... Read more

hemotune AG: Magnetic Blood Purification

hemotune AG is developping a revolutionary medical device for blood purification that combines cutting-edge scientific results from biomedicine and nanotechnology. It allows specific and direct remova... Read more

Lymphatica Medtech SA: Revolution in lymphedema therapy

Lymphatica is a clinical stage medical device development company that has designed and patented the first implantable system for chronic lymphedema treatment, which will improve the quality of life o... Read more

MUVON Therapeutics AG: Regain control with MUVON

MUVON enables healthy aging! We reverse age- or damage-related disability through functional skeletal muscle regeneration. MUVON's proprietary, cell-based regenerative platform technology induces succ... Read more

NanoFlex Robotics AG: Endo- and Neurovascular remote control robotics.

NanoFlex is developing a soft robotic system that allows the precise movement of specially made catheters in the vasculature. Those catheters are softer, more manoeuvrable, easier to use, and safer th... Read more

Spectroplast AG: Introducing Silicone to the World of 3D Printing

Spectroplast AG has developed the first Silicone 3D Printing technology to produce customised live- enhancing prosthetics and life-saving medical implants. The ETH spinoff has a positive impact on soc... Read more